Resultados de la búsqueda 511-520 of 1075 for Alternative

  1. Ensayos clínicos - Medicina pulmonar

    The purpose of this study is to to mechanistically investigate the effect of specific inspiratory muscle training on respiratory function, exercise capacity ...

  2. Oncología (médica) - Ensayos clínicos

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...

  4. Oncología (médica) - Ensayos clínicos

    In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate whether proton radiation therapy (proton RT) reduces acute gastrointestinal toxicities at the end of treatment compared ...

  6. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  7. Oncología (médica) - Ensayos clínicos

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this combination ...

  8. Trasplante de médula ósea - Médicos y departamentos - Mayo Clinic

    Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: Comparison among alternative ...

  9. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Oncología (médica) - Ensayos clínicos

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...